On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Serend-Ip GmbH's own share of each project, not the project's full budget.
- Horizon Europe€41k · 2 projects
- Horizon 2020€18k · 2 projects
Projects
4 EU-funded projects, newest first. Each links to the official record.
- CARESPartner
Human ECM-based platform for anti-cancer drug testing - CARES (CAncer dRug tESting)
Horizon Europe · 2023–2027 · Project on CORDIS ↗
€9ktheir share - HEPINIBPartner
Heparanase inhibition as a multifunctional targeting approach in cancer
Horizon Europe · 2023–2026 · Project on CORDIS ↗
€32ktheir share - €14ktheir share
- GLYCANCPartner
Matrix glycans as multifunctional pathogenesis factors and therapeutic targets in cancer
Horizon 2020 · 2015–2019 · Project on CORDIS ↗
€5ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Universitaet MuensterGermany · 4 shared projects
- Consejo Nacional de Investigaciones Cientificas y Tecnicas (Conicet)Argentina · 3 shared projects
- Uppsala UniversitetSweden · 2 shared projects
- Panepistimio PatronGreece · 2 shared projects
- Universita Degli Studi Dell'InsubriaItaly · 2 shared projects
- Universite de Reims Champagne-ArdenneFrance · 2 shared projects
- Celvia Cc ASEstonia · 2 shared projects
- Centre National de la Recherche Scientifique CNRSFrance · 1 shared project
- Consiglio Nazionale Delle RicercheItaly · 1 shared project
- The University of EdinburghUnited Kingdom · 1 shared project
- Karolinska InstitutetSweden · 1 shared project
- Politecnico di MilanoItaly · 1 shared project
- Technion - Israel Institute of TechnologyIsrael · 1 shared project
- Charite - Universitaetsmedizin BerlinGermany · 1 shared project
- Oulun YliopistoFinland · 1 shared project
- Rheinische Friedrich-Wilhelms-Universitat BonnGermany · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- biomaterials
- breast cancer
- carbohydrates
- drug discovery
- enzymes
- immunology
- inflammatory diseases
- microfluidics
- oncology
- public health
- stem cells
- surgery
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.